Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Guba

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Pathology, Research and Practice|February 12, 2022
Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parametersElise Pretzsch, Florian Bösch, Rumyana Todorova, et al.
International Journal of Molecular Sciences|March 11, 2023
The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary ComplicationsUlrich Wirth, Tianxiao Jiang, Josefine Schardey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapyHendrik Seeliger, Markus Guba, Gudrun E Koehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancerChristiane J Bruns, Gudrun E Koehl, Markus Guba, et al.
BMC Medical Ethics|February 14, 2018
Benefit in liver transplantation: a survey among medical staff, patients, medical students and non-medical university staff and studentsChristine Englschalk, Daniela Eser, Ralf J Jox, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2016
Time-dependent impact of age and comorbidities on long-term overall survival after liver resectionTobias S Schiergens, Andrea Lindenthaler, Michael N Thomas, et al.
Medicine|September 15, 2023
Percutaneous transhepatic biliary drainage (PTBD) in patients with biliary leakage: Technical and clinical outcomesSinan Deniz, Osman Öcal, Moritz Wildgruber, et al.
Annals of Surgery|February 5, 2011
Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterionDerek DuBay, Charbel Sandroussi, Lakhbir Sandhu, et al.
Langenbeck'S Archives of Surgery|May 12, 2023
Regional transplant rates depend more on physician-dependent variables than on proximity to transplant centerElnaz Payani, Nikolaus Börner, Dionysios Kolliogiannis, et al.
Langenbeck'S Archives of Surgery|March 20, 2026
Requirements for a successful implementation of liver transplantation as a treatment option for non-resectable colorectal liver metastases into clinical routine - a narrative reviewKilian Alexander Walter, Simon Moosburner, Tabea Kreutz, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Pathology, Research and Practice|February 12, 2022
Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parametersElise Pretzsch, Florian Bösch, Rumyana Todorova, et al.
International Journal of Molecular Sciences|March 11, 2023
The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary ComplicationsUlrich Wirth, Tianxiao Jiang, Josefine Schardey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapyHendrik Seeliger, Markus Guba, Gudrun E Koehl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancerChristiane J Bruns, Gudrun E Koehl, Markus Guba, et al.
BMC Medical Ethics|February 14, 2018
Benefit in liver transplantation: a survey among medical staff, patients, medical students and non-medical university staff and studentsChristine Englschalk, Daniela Eser, Ralf J Jox, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2016
Time-dependent impact of age and comorbidities on long-term overall survival after liver resectionTobias S Schiergens, Andrea Lindenthaler, Michael N Thomas, et al.
Medicine|September 15, 2023
Percutaneous transhepatic biliary drainage (PTBD) in patients with biliary leakage: Technical and clinical outcomesSinan Deniz, Osman Öcal, Moritz Wildgruber, et al.
Annals of Surgery|February 5, 2011
Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterionDerek DuBay, Charbel Sandroussi, Lakhbir Sandhu, et al.
Langenbeck'S Archives of Surgery|May 12, 2023
Regional transplant rates depend more on physician-dependent variables than on proximity to transplant centerElnaz Payani, Nikolaus Börner, Dionysios Kolliogiannis, et al.
Langenbeck'S Archives of Surgery|March 20, 2026
Requirements for a successful implementation of liver transplantation as a treatment option for non-resectable colorectal liver metastases into clinical routine - a narrative reviewKilian Alexander Walter, Simon Moosburner, Tabea Kreutz, et al.
Pageof 15